Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Cells, Free Full-Text
Prognostic role of multiple abnormal genes in non-small-cell lung cancer
Frontiers Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
Frontiers Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer
JCM, Free Full-Text
IJMS, Free Full-Text
Comprehensive molecular profiling of lung adenocarcinoma
Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies - ScienceDirect
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Frontiers Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer